MAHA Leader Calley Means Steps Down from Trump Administration Health Advisory Role
October 23, 2026

A Personalized Cancer Vaccine Lowers Melanoma Recurrence by 42%

The treatment is still experimental, but results from Moderna and Merck add scientific support for a vaccine-based approach to treating the cancer.

October 23, 2026
https://time.com/article/2026/10/22/moderna-merck-immunotherapy-lowers-melanoma-recurrence/